price

NASDAQ · HCM
HUTCHMED (China) Limited American Depositary Shares
Healthcare · Drug Manufacturers - Specialty & Generic
$14.09
Down-$0.21 (-1.49%)
Updated Sep 9, 2026, 1:24 AM
SID Score
7.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.39B
- P/E ratio
- 5.13
- Dividend yield
- 0.00%
- 52-week range
- $9.77 – $18.30
- Volume
- 150.5K
- Avg. volume
- 38.74K
Price performance
HCM price history
1M range · 19 trading sessions · Daily adjusted prices
HCM closed at $14.09 after 19 trading sessions, up 12.99% for the selected period.
- Last close
- $14.09
- Period change
- +12.99%
- Period low
- $11.91
- Period high
- $14.11
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $14.25 | $14.325 | $14.065 | $14.09 | 150.5K |
| Sep 3, 2026 | $13.60 | $14.23 | $13.51 | $14.11 | 511.72K |
| Sep 2, 2026 | $11.95 | $12.15 | $11.95 | $12.04 | 62.31K |
| Sep 1, 2026 | $12.14 | $12.14 | $11.80 | $11.91 | 74.51K |
| Aug 31, 2026 | $12.44 | $12.44 | $12.08 | $12.12 | 76.28K |
| Aug 28, 2026 | $12.40 | $12.48 | $12.34 | $12.38 | 59.14K |
| Aug 27, 2026 | $12.31 | $12.45 | $12.31 | $12.415 | 91.43K |
| Aug 26, 2026 | $12.41 | $12.56 | $12.34 | $12.35 | 62.75K |
| Aug 25, 2026 | $12.18 | $12.30 | $12.16 | $12.26 | 73.56K |
| Aug 24, 2026 | $12.58 | $12.58 | $12.09 | $12.18 | 56.36K |
| Aug 21, 2026 | $12.56 | $12.70 | $12.545 | $12.63 | 64.4K |
| Aug 20, 2026 | $12.65 | $12.67 | $12.47 | $12.56 | 49.95K |
| Aug 19, 2026 | $12.30 | $12.59 | $12.30 | $12.59 | 50.65K |
| Aug 18, 2026 | $12.60 | $12.77 | $12.48 | $12.64 | 284.84K |
| Aug 17, 2026 | $12.64 | $12.90 | $12.51 | $12.56 | 89.21K |
| Aug 14, 2026 | $12.19 | $12.27 | $12.08 | $12.20 | 13.09K |
| Aug 13, 2026 | $12.07 | $12.23 | $12.00 | $12.16 | 77.12K |
| Aug 12, 2026 | $12.36 | $12.40 | $12.21 | $12.25 | 34.29K |
| Aug 11, 2026 | $12.55 | $12.55 | $12.40 | $12.47 | 16.92K |
Latest HCM news
The latest Smart Investors Daily articles mentioning HCM.
Stock researchResearch & News · Analysis
Loading stock research…

